Skip to main content
. 2014 Nov 30;2014:629507. doi: 10.1155/2014/629507

Figure 4.

Figure 4

GSK-3β inhibition modulates the NF-κB and CREB activation following CLP. Mice were subjected to CLP and treated with either SB216763 (25 mg/kg, i.p.) or vehicle (DMSO). Liver samples were harvested at 20 h after CLP. NF-κB activity, as well as CREB activity, was assessed. Data are shown as mean ± SD. n = 6 per group. * P < 0.05, # P < 0.01 compared with vehicle-treated group.